# FDA Inspection 1028527 - Kaiser Permanente of the Mid-Atlantic States IRB #7 - October 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/kaiser-permanente-of-the-mid-atlantic-states-irb-7/27006e9f-6f43-460f-b07e-5f544c473425
Source feed: FDA_Inspections

> FDA Inspection 1028527 for Kaiser Permanente of the Mid-Atlantic States IRB #7 on October 10, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028527
- Company Name: Kaiser Permanente of the Mid-Atlantic States IRB #7
- Inspection Date: 2017-10-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1232973 - 2024-02-26](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-of-the-mid-atlantic-states-irb-7/1be0c97f-fa6e-467f-9ae6-6fc8a3479754)
- [FDA Inspection 1232973 - 2024-02-26](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-of-the-mid-atlantic-states-irb-7/9411ccfd-8d26-4c76-b589-f6c782b26581)
- [FDA Inspection 1232973 - 2024-02-26](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-of-the-mid-atlantic-states-irb-7/1c0d0408-3979-4e8d-b9b0-50f9f070ec41)

Company: https://www.keypedia.com/companies/kaiser-permanente-of-the-mid-atlantic-states-irb-7/dbeb21fe-cf58-4b63-8bbc-80cea2ba57a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c